Selective induction of the secretion of cathepsins B and L by cytokines in synovial fibroblast-like cells

British Journal of Rheumatology

Volumn 36, Issue 7, 1997, Pages 735-743

  Lemaire, R ^a   Huet, G ^b   Zerimech, F ^b   Grard, G ^b   Fontaine, C ^b   Duquesnoy, B ^b   Flipo, R M ^b  

^a UNIV LILLE   (France)

^b NONE

Author keywords

Cathepsins; Cytokines; Rheumatoid arthritis

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CATHEPSIN B; CATHEPSIN L; CYSTEINE PROTEINASE; CYTOKINE; ENZYME INHIBITOR; GAMMA INTERFERON; PLATELET DERIVED GROWTH FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME IMMUNOASSAY; ENZYME INDUCTION; ENZYME SUBSTRATE; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; JOINT DEGENERATION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIUM;

EID: 0030837038     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/36.7.735     Document Type: Article

References (47)

1. Fassbender HG. Histomorphological basis of articular cartilage destruction in rheumatoid arthritis. Coll Relat Res 1983;3:141-55.
2. Shiozawa S, Tokuhisa T. Contribution of synovial mesenchymal cells to the pathogenesis of rheumatoid arthritis. Semin Arthritis Rheum 1992;21:267-3.
3. Dayer JM, Krane SM, Russel GG, Robinson DR. Production of collagenase and prostaglandins by isolated synovial cells. Proc Natl Acad Sci USA 1976;73:945-9.
4. Chin JR, Murphy G, Werb Z. Stromelysin, a connective tissue-degrading metalloendopeptidase secreted by stimulated rabbit synovial fibroblasts in parallel with collagenase. J Biol Chem 1985;260:12367-76.
5. He C, Wilhelm SM, Pentland AP, Marmer BL, Grant GA, Eisen AZ et al. Tissue cooperation in a proteolytic cascade activating human interstitial collagenase. Proc Natl Acad Sci USA 1989;86:2632-6.
6. Hasty KA, Reife RA, Kang AH, Stuart JM. The role of stromelysin in the cartilage destruction that accompanies inflammatory arthritis. Arthritis Rheum 1990; 33:388-96.
7. Huet G, Flipo RM, Colin M, Janin A, Hemon B, Collyn-d'Hooghe M et al. Stimulation of the secretion of latent cysteine proteinase activity by Tumor Necrosis Factor α and interleukin-1. Arthritis Rheum 1993; 36:772-80.
8. Miossec P, Dinarello CA, Ziff M. Interleukin-1 lymphocytic chemotactic activity in rheumatoid arthritis synovial fluid. Arthritis Rheum 1986;29:461-70.
9. Wood DD, Ihrie EJ, Dinarello A, Cohen PL. Isolation of interleukin-1 like factor from human joint effusions. Arthritis Rheum 1983;26:975-83.
10. Firestein GS, Tsai V, Zvaifler NJ. Cellular immunity in the joint of patients with rheumatoid arthritis and other forms of chronic synovitis. Rheum Dis Clin North Am 1987;13:191-213.
11. Firestein GS, Zvaifler NJ. Peripheral blood and synovial fluid monocyte activation in inflammatory arthritis. II. Low levels of synovial fluid and synovial tissue interferon suggest that γ-interferon is not the primary macrophage activating factor. Arthritis Rheum 1987;30:864-71.
12. Lafyatis R, Thomson N. Remmers E, Flanders K, Roberts AB, Sporn M et al. Demonstration of local production of PDGF and TGF-beta by synovial tissue from patients with rheumatoid arthritis. Arthritis Rheum 1988;31:S62.
13. Chu CQ, Field M, Allard S, Abney E, Feldmann M, Maini RN. Detection of cytokines at the cartilage/pannus junction in patients with rheumatoid arthritis: implications for the role of cytokines in cartilage destruction and repair. Br J Rheumatol 1992;31:653-61.
14. Qu Z, Huang XN, Ahmadi P, Andresevic J, Planck SR, Hart CE et al. Expression of fibroblast growth factor in synovial tissue from patients with rheumatoid arthritis and degenerative joint disease. Lab Invest 1995;73:339-46.
15. Frisch SM, Ruley HE. Transcription from the stromelysin promoter is induced by interleukin-1 and repressed by dexamethasone. J Biol Chem 1987;262:16300-4.
16. Dayer JM, Rochemonteix B, Burrus B, Demczuck S, Dinarello CA. Human recombinant interleukin-1 stimulates collagenase and prostaglandin production by human synovial cells. J Clin Invest 1986;77:645-8.
17. 2 production by human synovial cells and dermal fibroblasts. J Exp Med 1985;162:2163-8.
18. Keffer J, Probert L, Cazlaris H, Georgopoulos S, Kaslaris E, Kioussis D et al. Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J 1991;10:4025-31.
19. Lafyatis R, Remmers EF, Roberts AB, Yocum DE, Sporn MB, Wilder RL. Anchorage-independent growth of synoviocytes of arthritic and normal joints: stimulation by exogenous platelet-derived growth factor and inhibition by transforming growth factor-beta and retinoids. J Clin Invest 1989;83:1267-76.
20. Remmers EF, Lafyatis R, Case JP, Roberts AB, Sporn MB, Wilder RL. Cytokine and growth regulation of synoviocytes from patients with rheumatoid arthritis and rats with streptococcal cell wall arthritis. Growth Factors 1990:2:179-88.
21. Goddard DH, Grossman SL, Williams WV, Weiner DB, Gross JL, Eidsvoog K et al. Regulation of synovial cell growth. Arthritis Rheum 1992;35:1296-303.
22. Amento EP, Bahn AK, McCullagh KG, Krane SM. Influences of gamma interferon on synovial fibroblast-like cells. J Clin Invest 1985;76:837-48.
23. 2, and collagenase release. Ann Rheum Dis 1990;49:512-6.
24. Alvaro-Gracia JM, Zvailfer NJ, Firestein GS. Cytokines in chronic inflammatory arthritis. V. Mutual antagonism between interferon-gamma and tumor necrosis factor-alpha on HLA-DR expression, proliferation, collagenase production and granulocyte macrophage colony-stimulating factor production by rheumatoid arthritis synoviocytes. J Clin Invest 1990;86:1790-8.
25. Mort JS, Recklies AD, Poole AR. Extracellular presence of the lysosomal proteinase cathepsin B in rheumatoid synovium and its activity at neutral pH. Arthritis Rheum 1984;27:509-15.
26. Etherington DJ, Maciewicz RA, Taylor MAJ, Wardale RJ, Silver IA, Murrills RA et al. The role of collagen-degrading cysteine proteinases in connective tissue metabolism. In: Turk V, ed. Cysteine proteinases and their inhibitors. Berlin: Walter de Gruyter, 1986:269-82.
27. Maciewicz RA, Wotton SF, Etherington DJ, Duance VC. Susceptibility of the cartilage collagens types II, IX and XI to degradation by the cysteine proteinases, cathepsins B and L. FEBS Lett 1990;269:189-93.
28. Zerimech F, Huet G, Balduyck M, Degand P. Cysteine proteinase activity in synovial fluids measured with a centrifugal analyzer. Clin Chem 1993;39:1751-3.
29. Huet G, Flipo RM, Richet C, Thiebaut C, Demeyer D, Balduyck M et al. Measurement of elastase and cysteine proteinases in synovial fluid of patients with rheumatoid arthritis, sero-negative spondylarthropathies, and osteoarthritis. Clin Chem 1992;38:1694-7.
30. Gabriejelcic D, Annan-Prah A, Rodic B, Rozman B, Cotic V, Turk V. Determination of cathepsin B and H in sera and synovial fluids of patients with different joint diseases. J Chem Clin Biochem 1990;28:149-53.
31. Maciewicz RA, Etherington DJ. Enzyme immuno-assay for cathepsins B and L in synovial fluids from patients with arthritis. Biochem Soc Trans 1988;16:812-3.
32. Trabandt A, Gay RE, Fassbender HG, Gay S. Cathepsin B in synovial cells at the site of joint destruction in rheumatoid arthritis. Arthritis Rheum 1991;34:1444-51.
33. Trabandt A, Aicher W, Gay RE, Sukhatme VP, Nilson-Hamilton M, Hamilton RT et al. Expression of the collagenolytic and ras-induced cysteine proteinase cathepsin L and proliferation-associated oncogenes in synovial cells of MRL/1 mice and patients with rheumatoid arthritis. Matrix 1990;10:349-61.
34. Hill PA, Buttle DJ, Jones SJ, Boyde A, Murata M, Reynolds JJ. Inhibition of bone resorption by selective inactivators of cysteine proteinases. J Cell Biochem 1994;56:118-30.
35. Lemaire R, Flipo RM, Monté D, Dupressoir T, Duquesnoy B, Cesbron JY et al. Synovial fibroblast-like cell transfection with the SV40 large T antigen induces a transformed phenotype and permits transient tumor formation. J Rheumatol 1994;21:1409-19.
36. Peterson GL. Modified procedure for protein assay. Anal Biochem 1977;83:346-56.
37. Qian F, Bajkowski AS, Steiner DF, Chan SJ, Frankfater A. Expression of five cathepsins in murine melanomas of varying metastasic potential and normal tissues. Cancer Res 1989;49:4870-5.
38. Lah T, Kokalj-Kunovar M, Strukelj B, Pungercar J, Barlic-Maganja D, Drolnic-Kosorok M et al. Stefins and lysosomal cathepsins B, L and D in human breast carcinoma. Clin Chem 1993;39:1751-3.
39. Chan SJ, San Segundo BS, McCormick MB, Steiner DF. Nucleotide and predicted amino acid sequences of cloned human and mouse preprocathepsin B cDNA. Proc Natl Acad Sci USA 1986;83:7721-5.
40. Church GM, Gilbert W. Genomic sequencing. Proc Natl Acad Sci USA 1984;81:1991-5.
41. Hamilton MN, Hamilton RT, Allen WR, Massoglia SL. Stimulation of the release of two glycoproteins from mouse 3T3 cells by growth factors and by agents that increase intralysosomal pH. Biochem Biophys Res Commun 1981;101:411-7.
42. Lah TT, Hawley M, Rock KL, Goldberg AL. Gamma-interferon causes a selective induction of the lysosomal proteases, cathepsins B and L, in macrophages. FEBS Lett 1995;363:85-9.
43. Kowanko IC, Ferrante A. Interferon-gamma increases human neutrophil-mediated cartilage proteoglycan degradation. Clin Exp Rheumatol 1992;10:123-9.
44. Takahashi H, Cease KB, Berzofsky JA. Identification of proteases that process distinct epitopes on the same protein. J Immunol 1989;142:2221-9.
45. Prence EM, Dong J, Sahagian GG. Modulation of the transport of a lysosomal enzyme by PDGF. J Cell Biol 1990;110:319-26.
46. Frick KK, Doherthy PJ, Gottesman MM, Scher CD. Regulation of the transcript for a lysosomal protein: evidence for a gene program modified by platelet-derived growth factor. Mol Cell Biol 1985;5:2582-9.
47. Gong QG, Chan SJ, Bajkowski AS, Steiner DF, Frankfater A. Characterization of the cathepsin B gene and multiple mRNAs in human tissues: evidence for alternative splicing of cathepsin B pre-mRNA. DNA Cell Biol 1993;12:299-309.